Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.

Keywords

Medicine, Nomogram, Prostatectomy, Prostate cancer, Urology

References

• The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy.Joseph G. Trapasso, Jean B. deKernion, Robert B. Smith — 1994
• Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.Alan W. Partin, Charles R. Pound, J. Quentin Clemens — 1993
• Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control.Charles R. Pound, Alan W. Partin, Jonathan I. Epstein — 1997
• Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy.Alan W. Partin, James L. Mohler, Steven Piantadosi — 1995
• Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-1ra Phase III Sepsis Syndrome Study Group.William A. Knaus, Frank E. Harrell, John F. LaBrecque — 1996
• A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.Michael W. Kattan, James A. Eastham, Alan M. F. Stapleton — 1998
• Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomyJohn J. Bauer, Roger R. Connelly, Isabell A. Sesterhenn — 1997
• Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.Thomas M. Wheeler, Özdal Dillioğlugil, Michael W. Kattan — 1998
• Short-term mortality predictions for critically ill hospitalized adults: science and ethics.William A. Knaus, Douglas P. Wagner, Joanne Lynn — 1991
• The new american joint committee on cancer and international union against cancer tnm classification of prostate cancerMakoto Ohori, Thomas M. Wheeler, Peter T. Scardino — 1994
• Evaluation of a Nomogram used to predict the pathologic stage of clinically localized prostate carcinomaMichael W. Kattan, Alan M. F. Stapleton, Thomas M. Wheeler — 1997
• Correlation of pathologic findings with progression after radical retropubic prostatectomyJonathan I. Epstein, Galina Pizov, Patrick C. Walsh — 1993
• The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis.William A. Knaus — 1993
• The role of retroperitoneal lymphadenectomy in mature teratoma of the testis.Axel Heidenreich, Judd W. Moul, David G. McLeod — 1997
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.Alan W. Partin, Michael W. Kattan, E N Subong — 1997
• The Mechanisms and Prognostic Significance of Seminal Vesicle Involvement by Prostate CancerMakoto Ohori, Peter T. Scardino, STEPHEN L. LAPIN — 1993
• Prognostic significance of positive surgical margins in radical prostatectomy specimens.Makoto Ohori, Thomas M. Wheeler, Michael W. Kattan — 1995
• Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer.John J. Bauer, Roger R. Connelly, ISABELL A. SETERHENN — 1998
• Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators.Robert M. Califf, Lynn H. Woodlief, Frank E. Harrell — 1997
• Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting.Judd W. Moul, Thomas H. Douglas, William F. McCarthy — 1996

Cited by

• Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomy.Manuel David García Brenes — 2002
• Failure after radical prostatectomy.Варданян Саркис Галустович, Гальцев Юрий Викторович, Тартаковский Дмитрий Федорович — 2003
• Decisions at Hand: A Decision Support System on HandheldsBlaž Zupan, A Porenta, Gaj Vidmar — 2001
• Update of staging and risk assessment for prostate cancer patientsP. Laporte — 2004
• Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.Ramez Elmasri, Sheng-Chieh Jack Fu — 2010
• Does prostate specific antigen density correlates with aggressiveness of the prostate cancer?S. Saidi, V Georgiev, Сотир Ставридис — 2009
• Landmarks in prostate cancer芳一 今西, 敏則 根本 — 2018
• Metastasectomy for isolated bilateral adrenal metastases in hormone-refractory prostate cancer.Manish Kohli, Sanjaya Viswamitraa, Robert F. Schaefer — 2006
• Radiothérapie des adénocarcinomes de la prostateP. Pommier, É. Martin, Lagrange Jl — 2007
• CYP17A1 polymorphisms and clinical outcome of patients with metastatic castration-resistant prostate cancer treated with abirateroneDe Giorgi, Ugo Federico Francesco <1970> — 2014
• Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy.Kevin M. Slawin, Christopher J. DiBlasio, Michael W. Kattan — 2004
• Orange and Decisions-at-Hand: Bridging Predictive Data Mining and Decision SupportBlaž Zupan, Janez Demšar, Michael W. Kattan — 2001
• Quels marqueurs circulants pour quels cancers?Benoît You — 2007
• Sural Nerve Interposition Grafting during Radical Prostatectomy.Kevin M. Slawin, Eduardo I. Canto, Shahrokh F. Shariat — 2002
• Radiotherapy for locally recurrent prostate cancer.John P. Kirkpatrick, Mitchell S. Anscher — 2005
• New algorithms for the staging of kidney cancer.D. Leibovici, Avishay Sella, I. Y. Siegel — 2003
• Chemoprevention in prostate cancer.Chadi Nabhan, Raymond C. Bergan — 2001
• Predictive models for newly diagnosed prostate cancer patients.William T. Lowrance, Peter T. Scardino — 2009
• Radiotherapy after ProstatectomyGiuseppe Sanguineti, P. Franzone, Laura Culp — 2002
• 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?Francesco Ceci, Christian Uprimny, Bernhard Nilica — 2015

Related papers

• Nomograms as Predictive Tools for Prostate Cancer Patients Who Had Radical ProstatectomySaadettin Eskiçorapçı, Cenk Acar, Zafer Sınık — 2011
• Biochemical recurrence after radical prostatectomy: what does it mean?Rafael Tourinho‐Barbosa, Victor Srougi, Igor Nunes‐Silva — 2018
• PD08-04 A NOVEL PROGNOSTIC MODEL FOR PATIENTS UNDERGOING SALVAGE RADIOTHERAPY FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMYTom Van Den Broeck, Milonas Daimantas, N. Fossati — 2021
• Statins Prevent Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Single-center Retrospective Study with a Median Follow-up of 51.20 MonthsRoberto Jarimba, João Pedroso Lima, Miguel Eliseu — 2020
• Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.Sergey Shikanov, Jie Song, Cassandra Royce — 2009
• The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomyMasaki Shiota, Akira Yokomizo, Ario Takeuchi — 2014
• [Retrospective analysis of predicting biochemical recurrence after initial radical prostatectomy].Kazuhiro Namura, Tatsuaki Onuki, Mitsuru Kouno — 2013
• Biochemical recurrence after radical prostatectomy: is the disease or the surgeon to blame?Adnan Şimşir, Çağ Çal, Rashad Mammadov — 2011
• PD07-09 PROSTATE SPECIFIC ANTIGEN TESTING AFTER RADICAL PROSTATECTOMY: CAN WE STOP AT 20 YEARS?Wesley Ludwig, Zhaoyong Feng, Bruce J. Trock — 2017
• Predictive factors of biochemical recurrence after radical prostatectomy for high‐risk prostate cancerYukiko Murata, Katsunori Tatsugami, Masahiro Yoshikawa — 2018